Immunogenicity and Safety of GSK Biologicals' IPV (Poliorix) in Infants.
Phase of Trial: Phase III
Latest Information Update: 27 Apr 2017
At a glance
- Drugs Poliovirus vaccine inactivated (Primary) ; Poliovirus vaccine live oral
- Indications Poliomyelitis
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 09 Jul 2010 Actual number of patients added to 1101 as reported by ClinicalTrials.gov.
- 09 Jul 2010 Planned end date added to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 09 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History